missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18175371

Human CXCR6 Alexa Fluor 647-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  R&D Systems FAB699RR-100UG

Product Code. 18175371

  • € 491.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CXCR6 Monoclonal specifically detects CXCR6 in Human samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CXCR6
Monoclonal
Alexa Fluor 647
Supplied 0.2Mg/mL in a saline solution containing BSA and Sodium Azide.
Bonzo, BONZOG-protein coupled receptor bonzo, CD186, CD186 antigen, CDw186, chemokine (C-X-C motif) receptor 6, C-X-C chemokine receptor type 6, CXCR6, CXC-R6, CXCR-6, G protein-coupled receptor, STRL33, STRL33G-protein coupled receptor STRL33, TYMSTRCD186
NS0 mouse myeloma cell line transfected with human CXCR6 Met1-Leu342 Accession # O00574
100 μg
10663
Human
Supernatant
Flow Cytometry
56811R
Flow Cytometry 0.25-1μg/106 cells
O00574
Mouse
Protein A or G purified from cell culture supernatant
Primary
Detects human CXCR6 in direct ELISAs.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.